Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.85 |
| ▸ | CHAT | P28329 | 2/20 | 0.79 |
| ▸ | EP300 | Q09472 | 4/20 | 0.78 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.78 |
| ▸ | AURKA | O14965 | 1/20 | 0.78 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.78 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL188195 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL18327200 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL28887972 | 0.95 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL21327973 | 0.95 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL16428887 | 0.95 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29849789 | 0.95 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29238963 | 0.95 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL30221151 | 0.95 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL16018847 | 0.95 | NAA50 (0.89) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL20211012 | 0.95 | NAA50 (0.89) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022407-A1 | METHOD, ENZYME COMPOSITION, NUCLEIC ACID COMPOSITION, AND TRANSGENIC MICROORGANISM FOR PRODUCING ISOPRENE GLYCOL | NATIONAL YANG MING CHIAO TUNG UNIV (TW) | 2026-01-22 | — | — | US | claimed |
| US-12497635-B2 | Means and methods for producing isobutene from acetyl-CoA | GLOBAL BIOENERGIES (FR) | 2025-12-16 | — | — | US | claimed |
| US-20260022407-A1 | METHOD, ENZYME COMPOSITION, NUCLEIC ACID COMPOSITION, AND TRANSGENIC MICROORGANISM FOR PRODUCING ISOPRENE GLYCOL | NATIONAL YANG MING CHIAO TUNG UNIV (TW) | 2026-01-22 | — | — | US | disclosed |
| US-12497635-B2 | Means and methods for producing isobutene from acetyl-CoA | GLOBAL BIOENERGIES (FR) | 2025-12-16 | — | — | US | disclosed |
| US-12460234-B2 | Synthesis of isoprenoids and derivatives | WILLIAM MARSH RICE UNIVERSITY (US) | 2025-11-04 | — | — | US | disclosed |
| US-20250327097-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2025-10-23 | — | — | US | disclosed |
| US-12084704-B2 | Methods for producing isobutene from 3-methylcrotonic acid | GLOBAL BIOENERGIES (FR) | 2024-09-10 | — | — | US | disclosed |
| EP-4399284-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | Global Bioenergies (FR) | 2024-07-17 | — | — | EP | disclosed |
| US-20240182932-A1 | SYNTHESIS OF ISOPRENOIDS AND DERIVATIVES | WILLIAM MARSH RICE UNIVERSITY (US) | 2024-06-06 | — | — | US | disclosed |
| EP-3622080-B1 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2024-03-27 | — | — | EP | disclosed |
| EP-4319746-A1 | METHODS OF TREATING METHYLMALONIC ACIDEMIA AND PROPIONIC ACIDEMIA | Hemoshear Therapeutics, Inc. (US) | 2024-02-14 | — | — | EP | disclosed |
| WO-2023031482-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2023-03-09 | — | — | WO | disclosed |
| EP-4144838-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | Global Bioenergies (FR) | 2023-03-08 | — | — | EP | disclosed |
| WO-2022216848-A1 | METHODS OF TREATING METHYLMALONIC ACIDEMIA AND PROPIONIC ACIDEMIA | Hemoshear Therapeutics, Inc. (US) | 2022-10-13 | — | — | WO | disclosed |
| WO-2022136207-A1 | IMPROVED MEANS AND METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2022-06-30 | — | — | WO | disclosed |
| US-20220145336-A1 | MEANS AND METHODS FOR PRODUCING ISOBUTENE FROM ACETYL-COA | GLOBAL BIOENERGIES (FR) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022407-A1 | METHOD, ENZYME COMPOSITION, NUCLEIC ACID COMPOSITION, AND TRANSGENIC MICROORGANISM FOR PRODUCING ISOPRENE GLYCOL | ACACB, ACACA, HMGCR | NAA50 448/4885CHAT 213/4885EP300 693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.